First Time Loading...

Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365

Watchlist Manager
Qianjiang Yongan Pharmaceutical Co Ltd Logo
Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
Watchlist
Price: 8.3 CNY 0.73%
Updated: May 6, 2024

Qianjiang Yongan Pharmaceutical Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qianjiang Yongan Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
Net Income (Common)
¥25.1m
CAGR 3-Years
-43%
CAGR 5-Years
-31%
CAGR 10-Years
-5%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Income (Common)
¥3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Income (Common)
¥2.8B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Income (Common)
¥4.2B
CAGR 3-Years
-10%
CAGR 5-Years
2%
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Income (Common)
¥4.1B
CAGR 3-Years
-9%
CAGR 5-Years
3%
CAGR 10-Years
6%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Net Income (Common)
¥755.6m
CAGR 3-Years
36%
CAGR 5-Years
28%
CAGR 10-Years
N/A

See Also

What is Qianjiang Yongan Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
25.1m CNY

Based on the financial report for Sep 30, 2023, Qianjiang Yongan Pharmaceutical Co Ltd's Net Income (Common) amounts to 25.1m CNY.

What is Qianjiang Yongan Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-5%

Over the last year, the Net Income (Common) growth was -87%. The average annual Net Income (Common) growth rates for Qianjiang Yongan Pharmaceutical Co Ltd have been -43% over the past three years , -31% over the past five years , and -5% over the past ten years .